Private Market View

InSilico Medicine Cayman (HKG: 03696)

Biotech · Hong Kong, MA · Founded 2014 · Publicly Held

Last price · $/share
Implied valuation
$1.7B
Total raised
$841.9M
Last round
Series E extension (final close)
Jun 2025
What is InSilico Medicine Cayman (HKG: 03696) worth?
$1.7Blast known valuation

InSilico Medicine Cayman (HKG: 03696) last raised $13.0M in its Series E extension (final close) (Jun 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 6 rounds
  • ·The complete investor list — 50 names
  • ·Watchlist + deal alerts for InSilico Medicine Cayman (HKG: 03696)
Create free account
No card required

Funding history

6 rounds
DateRoundRaisedPost-money
Jun 2025Series E extension (final close)$13.0M
Mar 2025Series E$110.0M
Aug 2022Series D2$35.0M
Jun 2022Series D$60.0M
Jun 2021Series C$255.0M
Sep 2019Series B$37.0M

How InSilico Medicine Cayman (HKG: 03696)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For InSilico Medicine Cayman (HKG: 03696), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is InSilico Medicine Cayman (HKG: 03696) worth?
InSilico Medicine Cayman (HKG: 03696)'s last known valuation is $1.7B.
How much has InSilico Medicine Cayman (HKG: 03696) raised?
InSilico Medicine Cayman (HKG: 03696) has raised $841.9M in total funding across 6 recorded rounds.
When did InSilico Medicine Cayman (HKG: 03696) last raise?
InSilico Medicine Cayman (HKG: 03696) last raised in Jun 2025 (Series E extension (final close)), raising $13.0M.